IL1B and diabetes mellitus: No changes in plasma levels of OPN, IL-10, TNFα, IL-12p70, IL-1β, IL-6, and KC were observed in response to diabetes or NFAT inhibition; however plasma IFN-γ was reduced in diabetic animals that had been treated with A-285222 (Supplementary Table S1).